Health & Welfare
ViAqua Therapeutics secures funding for RNA-based aquaculture disease management
A funding round of $8.25 million enables ViAqua to scale RNA-based solutions for aquaculture disease and invest in R&D for future products.
Health & Welfare
A funding round of $8.25 million enables ViAqua to scale RNA-based solutions for aquaculture disease and invest in R&D for future products.